HK1013998A1 - Carbapenems containing a carboxy substituted phenyl group processes for their preparation intermediates and use as antibiotics - Google Patents

Carbapenems containing a carboxy substituted phenyl group processes for their preparation intermediates and use as antibiotics

Info

Publication number
HK1013998A1
HK1013998A1 HK98115416A HK98115416A HK1013998A1 HK 1013998 A1 HK1013998 A1 HK 1013998A1 HK 98115416 A HK98115416 A HK 98115416A HK 98115416 A HK98115416 A HK 98115416A HK 1013998 A1 HK1013998 A1 HK 1013998A1
Authority
HK
Hong Kong
Prior art keywords
carbapenems
antibiotics
phenyl group
substituted phenyl
carboxy substituted
Prior art date
Application number
HK98115416A
Other languages
English (en)
Inventor
Michael John Betts
Gareth Morse Davies
Michael Lingard Swain
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of HK1013998A1 publication Critical patent/HK1013998A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568—Four-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK98115416A 1992-02-04 1998-12-24 Carbapenems containing a carboxy substituted phenyl group processes for their preparation intermediates and use as antibiotics HK1013998A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929202298A GB9202298D0 (en) 1992-02-04 1992-02-04 Antibiotic compounds
PCT/GB1993/000217 WO1993015078A1 (en) 1992-02-04 1993-02-02 Carbapenems containing a carboxy substituted phenyl group, processes for their preparation, intermediates and use as antibiotics

Publications (1)

Publication Number Publication Date
HK1013998A1 true HK1013998A1 (en) 1999-09-17

Family

ID=10709764

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98115416A HK1013998A1 (en) 1992-02-04 1998-12-24 Carbapenems containing a carboxy substituted phenyl group processes for their preparation intermediates and use as antibiotics

Country Status (35)

Country Link
US (7) US5478820A (de)
EP (1) EP0579826B1 (de)
JP (1) JP2730600B2 (de)
KR (1) KR100200986B1 (de)
CN (1) CN1036006C (de)
AP (1) AP398A (de)
AT (1) ATE173262T1 (de)
AU (1) AU668133B2 (de)
CA (1) CA2106370C (de)
CZ (1) CZ286878B6 (de)
DE (2) DE69322007T2 (de)
DK (1) DK0579826T3 (de)
ES (1) ES2123654T3 (de)
FI (1) FI104074B1 (de)
GB (2) GB9202298D0 (de)
GE (1) GEP20022694B (de)
HK (1) HK1013998A1 (de)
HR (1) HRP930103B1 (de)
HU (3) HU213675B (de)
IL (1) IL104588A (de)
LU (1) LU90970I2 (de)
MY (1) MY111685A (de)
NL (1) NL300104I2 (de)
NO (2) NO304315B1 (de)
NZ (2) NZ246917A (de)
PL (3) PL174649B1 (de)
RU (1) RU2117659C1 (de)
SG (1) SG48817A1 (de)
SI (1) SI9300056B (de)
SK (1) SK280890B6 (de)
TW (1) TW408124B (de)
UA (1) UA44885C2 (de)
WO (1) WO1993015078A1 (de)
YU (1) YU48998B (de)
ZA (1) ZA93453B (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
CA2106330A1 (en) * 1992-10-07 1994-04-08 Patrice J. Siret Antibiotic compounds
US5602118A (en) * 1993-03-16 1997-02-11 American Cyanamid Company 2-thiosubstituted carbapenems
GB9515975D0 (en) * 1995-08-04 1995-10-04 Zeneca Ltd Chemical compounds
UA62920C2 (en) * 1996-05-28 2004-01-15 Merck & Co Inc Carbapeneme antibiotic, a composition and a method for the preparation
HRP970281B1 (en) * 1996-05-28 2002-04-30 Merck & Co Inc Carbapenem antibiotic, composition and method of preparation
AR008255A1 (es) * 1996-07-12 1999-12-29 Merck & Co Inc Procedimiento para sintetizar antibioticos de carbapenem
US6946468B1 (en) 1996-08-17 2005-09-20 Zeneca Limited 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors
AU714155B2 (en) * 1996-10-10 1999-12-23 Merck & Co., Inc. Process for synthesizing carbapenem side chain intermediates
US5877328A (en) * 1996-10-10 1999-03-02 Merck & Co., Inc. Process for synthesizing carbapenem side chain intermediates
AU725298B2 (en) * 1996-10-28 2000-10-12 Merck & Co., Inc. Stabilized carbapenem antibiotic compositions and method of making
US6180783B1 (en) 1997-06-16 2001-01-30 Merck & Co., Inc. Stabilized carbapenem intermediates and improved process for carbapenem synthesis
WO1998057973A1 (en) * 1997-06-16 1998-12-23 Merck & Co., Inc. Stabilized carbapenem intermediates and synthetic use
CA2294341C (en) * 1997-07-10 2007-09-25 Merck & Co., Inc. Crystalline forms of antibiotic side chain intermediates
US5965747A (en) * 1997-07-10 1999-10-12 Merck & Co., Inc. Crystalline forms of antibiotic side chain intermediates
US5872250A (en) * 1997-07-30 1999-02-16 Merck & Co., Inc. Process for synthesizing carbapenem antibiotics
US6504027B1 (en) 1998-03-02 2003-01-07 Merck & Co., Inc. Decarboxylation process for synthesizing carbapenem antibiotics
AU749234B2 (en) * 1998-03-02 2002-06-20 Merck Sharp & Dohme Corp. Process for synthesizing carbapenem antibiotics
ATE263766T1 (de) 1998-06-17 2004-04-15 Merck & Co Inc Verfahren zur synthese von carbapenem- zwischenprodukten
US6486150B2 (en) 1999-10-29 2002-11-26 Merck & Co., Inc. Process for formulation of antibiotic compounds
US6548492B1 (en) 1999-10-29 2003-04-15 Merck & Co., Inc. Process for formulation of carbapenem antibiotic compositions
GB9930318D0 (en) 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
GB9930317D0 (en) * 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
AR035728A1 (es) * 2001-01-16 2004-07-07 Merck & Co Inc Proceso perfeccionado para la sintesis de carbapenem
CA2457642C (en) * 2001-09-26 2009-01-06 Merck & Co., Inc. Crystalline forms of ertapenem sodium
DK1474426T3 (da) * 2001-09-26 2011-11-21 Merck Sharp & Dohme Fremgangsmåde til fremstilling af carbapenemforbindelser
EP1446009A2 (de) * 2001-11-08 2004-08-18 Merck & Co., Inc. Verbindungen zur behandlung von anthrax
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
ES2323527T3 (es) * 2002-05-29 2009-07-20 MERCK & CO., INC. Compuestos utiles en el tratamiento del carbunco y en la inhibicion del factor letal.
WO2005111986A2 (en) * 2004-05-07 2005-11-24 Infinium Labs, Inc. Multi-position multi-level user interface system
EP1747212A4 (de) * 2004-05-11 2009-03-25 Merck & Co Inc Verfahren zur herstellung von n-sulfonierten aminosäure-derivaten
US20100003276A1 (en) * 2004-12-07 2010-01-07 Hermes Jeffery D Methods for treating anthrax and inhibiting lethal factor
CN100344613C (zh) * 2005-10-20 2007-10-24 上海交通大学 (2s,4s)－1－(4－硝基苄氧羰基)－2－[(3－烯丙氧羰基)－苯基氨基甲酰基]－吡咯烷－4－基硫醇的制备方法
ATE529111T1 (de) 2005-12-07 2011-11-15 Basilea Pharmaceutica Ag Nützliche monobactam-antibiotika
AU2012233003B2 (en) * 2005-12-07 2014-12-18 Basilea Pharmaceutica Ag Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
US8293894B2 (en) * 2006-11-20 2012-10-23 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of carbapenem antibiotic
CN101357916B (zh) * 2007-06-22 2010-12-15 山东轩竹医药科技有限公司 含有二氢咪唑甲酰胺基的培南化合物
CN101367807B (zh) * 2007-06-28 2011-01-12 山东轩竹医药科技有限公司 被巯基吡咯烷甲酰胺基吡啶取代的培南衍生物
CN101367815B (zh) * 2007-06-28 2012-07-04 山东轩竹医药科技有限公司 六元环甲酰胺取代的巯基吡咯烷碳青霉烯化合物
CN101362760B (zh) * 2007-08-07 2010-12-15 山东轩竹医药科技有限公司 1β-甲基碳代青霉烯化合物
CN101362761B (zh) * 2007-08-12 2011-05-18 山东轩竹医药科技有限公司 含有巯基哌啶的碳代青霉烯抗生素
CN101412720B (zh) * 2007-08-27 2011-05-18 山东轩竹医药科技有限公司 含有巯基氮杂环乙烯基的碳青霉烯化合物
CN101376641B (zh) * 2007-08-28 2010-12-08 上海医药工业研究院 碳青霉烯类青霉素厄他培南的中间体及其制备方法和应用
EP2505191A1 (de) 2008-06-11 2012-10-03 Ranbaxy Laboratories Limited Lypholisierte Carbapenem-Antibiotikumzusammensetzung
CA2732619A1 (en) * 2008-07-30 2010-02-04 Ranbaxy Laboratories Limited Process for the preparation of carbapenem compounds
RU2521391C2 (ru) * 2008-09-18 2014-06-27 Ману ЧАУДХАРИ Новые однократные единичные составы карбапенема и аминогликозида
JP2012525339A (ja) 2009-04-30 2012-10-22 石葯集団中奇制葯技▲術▼（石家庄）有限公司 エルタペネムの中間体、エルタペネムを含む組成物およびそれらの調製方法
WO2011048583A1 (en) 2009-10-23 2011-04-28 Ranbaxy Laboratories Limited Process for the preparation of carbapenem compounds
US8729260B2 (en) 2010-05-19 2014-05-20 Savior Lifetec Corporation Process for the preparation of carbapenem using cabapenem intermediates and recovery of cabapenem
CN102558182B (zh) * 2010-12-31 2015-02-11 石药集团中奇制药技术（石家庄）有限公司 一种厄他培南钠晶型及其制备方法
US8691803B2 (en) 2011-01-24 2014-04-08 Savior Lifetec Corporation Process for the preparation of antibiotic compounds
WO2013121279A2 (en) * 2012-02-14 2013-08-22 Aurobindo Pharma Limited Process to prepare ertapenem
CA2887098A1 (en) * 2012-10-12 2014-04-17 Sandoz Ag Preparation of ertapenem intermediates
JP2016517435A (ja) * 2013-03-15 2016-06-16 カラ ファーマシューティカルズ インコーポレイテッド メロペネム誘導体及びその使用
WO2015087245A1 (en) 2013-12-11 2015-06-18 Unimark Remedies Ltd. Process for preparation of ertapenem and salts thereof
MX2018011095A (es) 2016-03-16 2019-01-10 Orchid Pharma Ltd Compuestos de carbapenem.
CN106565579A (zh) * 2016-06-26 2017-04-19 宁夏海诚电化信息科技有限公司 一种尔它培南侧链生产工艺
CN110698480B (zh) * 2018-07-09 2023-09-08 武汉启瑞药业有限公司 一种厄他培南中间体的合成及纯化方法
MX2021008937A (es) * 2019-01-23 2021-11-12 Glycolysis Biomed Co Ltd Compuestos de beta-lactama o sales de los mismos para su uso en la prevencion o tratamiento de accion prolongada del trastorno del metabolismo de la glucosa.

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4206219A (en) * 1978-10-24 1980-06-03 Merck & Co., Inc. 6- and 1-Substituted-1-carbadethiapen-2-em-3-carboxylic acid
US4232036A (en) * 1978-10-24 1980-11-04 Merck & Co., Inc. 6-, 1- and 2-Substituted-1-carbadethiapen-2-em-3-carboxylic acids
US4208422A (en) * 1978-10-24 1980-06-17 Merck & Co., Inc. 1-Substituted-pen-2-em-3-carboxylic acids
US4218462A (en) * 1978-10-24 1980-08-19 Merck & Co., Inc. 6-(1-Hydroxyethyl)-2-(2-aminoethylthio)-1-substituted-1-carbade-thiapen-2-em-3-carboxylic acids
EP0082133A3 (en) * 1979-04-19 1983-07-20 Merck & Co. Inc. A process for preparing intermediates useful for preparing 2-substituted-6-substituted-1-carbadethiapen-2-em-3-carboxylic acids
US4746736A (en) * 1982-09-28 1988-05-24 Bristol-Myers Company Carbapenem antibiotics
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
JPS60202886A (ja) * 1984-03-27 1985-10-14 Sankyo Co Ltd １―置換カルバペネム―３―カルボン酸誘導体
JPS60233076A (ja) * 1984-05-03 1985-11-19 Sumitomo Chem Co Ltd 新規なβ−ラクタム化合物およびその製造法
DE3579888D1 (de) * 1984-11-08 1990-10-31 Sumitomo Pharma Carbapenemverbindungen und deren herstellung.
FI81576C (fi) * 1984-12-25 1990-11-12 Sankyo Co Foerfarande foer framstaellning av derivat av 6-(1-hydroxietyl)-2-(1,2-disubstituerade-4-pyrrolidinyltio)-2- karbapenem-3-karboxylsyra, vilka aer anvaendbara som laekemedel.
DE3780344T2 (de) * 1986-03-27 1993-01-28 Sumitomo Pharma Beta-lactam-verbindungen und deren herstellung.
US4974544A (en) * 1986-10-07 1990-12-04 Ricoh Company, Co. Vapor deposition apparatus
US4963544A (en) * 1988-05-23 1990-10-16 Fujisawa Pharmaceutical Company, Ltd. 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
US5194624A (en) * 1988-05-23 1993-03-16 Fujisawa Pharmaceutical Co., Ltd. Intermediates for the preparation of compounds of antimicrobial activity
GB8923844D0 (en) * 1989-10-23 1989-12-13 Fujisawa Pharmaceutical Co Carbapenem compounds
IE910606A1 (en) * 1990-02-23 1991-08-28 Sankyo Co Carbapenem derivatives having antibiotic activity, their¹preparation and their use
US5554606A (en) * 1990-03-12 1996-09-10 Zeneca Limited Antibiotic compounds
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
GB9107342D0 (en) * 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
GB9107341D0 (en) * 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
JP2559949B2 (ja) * 1991-06-04 1996-12-04 三共株式会社 １−メチルカルバペネム誘導体
ZA929008B (en) * 1991-12-13 1993-05-21 Bristol Myers Squibb Co Piperazinyl- and piperidinyl-cyclohexanols.
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
CA2091309A1 (en) * 1992-03-26 1993-09-27 Frederic H. Jung Antibiotic compounds
GB9304156D0 (en) * 1992-03-26 1993-04-21 Zeneca Ltd Antibiotic compounds
CA2099817A1 (en) * 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
CA2099818A1 (en) * 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
CA2099811A1 (en) * 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
CA2106141A1 (en) * 1992-09-28 1994-03-29 Michael J. Betts Antibiotic compounds

Also Published As

Publication number Publication date
RU2117659C1 (ru) 1998-08-20
CZ286878B6 (en) 2000-07-12
EP0579826B1 (de) 1998-11-11
PL174936B1 (pl) 1998-10-30
HRP930103A2 (en) 1994-12-31
TW408124B (en) 2000-10-11
GB9300456D0 (en) 1993-03-03
NO2002010I2 (no) 2005-03-11
ZA93453B (en) 1993-08-05
AU668133B2 (en) 1996-04-26
IL104588A0 (en) 1993-06-10
AP398A (en) 1995-08-29
NL300104I1 (nl) 2002-12-02
SI9300056B (sl) 2000-02-29
JPH06506704A (ja) 1994-07-28
US20020042408A1 (en) 2002-04-11
US6187804B1 (en) 2001-02-13
NO304315B1 (no) 1998-11-30
DE10299041I2 (de) 2003-06-12
US5652233A (en) 1997-07-29
HUT66514A (en) 1994-12-28
US7041836B2 (en) 2006-05-09
CN1036006C (zh) 1997-10-01
PL174649B1 (pl) 1998-08-31
NO2002010I1 (no) 2002-10-09
FI104074B (fi) 1999-11-15
US5478820A (en) 1995-12-26
CZ206793A3 (en) 1994-04-13
AP9300480A0 (en) 1993-01-31
IL104588A (en) 1999-03-12
SI9300056A (en) 1993-09-30
CA2106370A1 (en) 1993-08-05
NO933530D0 (no) 1993-10-01
US7342005B2 (en) 2008-03-11
US6521612B2 (en) 2003-02-18
DE69322007T2 (de) 1999-04-01
JP2730600B2 (ja) 1998-03-25
DE69322007D1 (de) 1998-12-17
US5856321A (en) 1999-01-05
EP0579826A1 (de) 1994-01-26
HU213675B (en) 1997-09-29
UA44885C2 (uk) 2002-03-15
WO1993015078A1 (en) 1993-08-05
YU5493A (sh) 1996-05-20
NL300104I2 (nl) 2003-02-03
FI104074B1 (fi) 1999-11-15
KR100200986B1 (ko) 1999-06-15
GEP20022694B (en) 2002-05-10
CA2106370C (en) 2003-11-25
NZ246917A (en) 1995-09-26
US20050209212A1 (en) 2005-09-22
AU3457493A (en) 1993-09-01
NO933530L (no) 1993-10-04
YU48998B (sh) 2003-04-30
US20030144264A1 (en) 2003-07-31
HUT64764A (en) 1994-02-28
ES2123654T3 (es) 1999-01-16
DE10299041I1 (de) 2003-02-20
LU90970I2 (fr) 2002-12-09
HU9302777D0 (en) 1993-12-28
FI930474A (fi) 1993-08-05
MY111685A (en) 2000-11-30
SK280890B6 (sk) 2000-09-12
GB9202298D0 (en) 1992-03-18
ATE173262T1 (de) 1998-11-15
HRP930103B1 (en) 1999-12-31
PL174601B1 (pl) 1998-08-31
SK106393A3 (en) 1994-04-06
NZ272038A (en) 1997-07-27
DK0579826T3 (da) 1999-07-26
SG48817A1 (en) 1998-05-18
HU211840A9 (en) 1995-12-28
CN1079224A (zh) 1993-12-08
FI930474A0 (fi) 1993-02-03

Similar Documents

Publication Publication Date Title
HK1013998A1 (en) Carbapenems containing a carboxy substituted phenyl group processes for their preparation intermediates and use as antibiotics
AU4084193A (en) Toothbrush
AU5151293A (en) Oral hygiene composition
EP0717633A4 (de) Wachstums-differenzierungsfaktor-7
AU4466793A (en) Spray can
SG91908A1 (en) Novel 2-thiosubstituted carbapenems
AU5067593A (en) Novel cleaning compositions
ZW3493A1 (en) Antibiotic compounds
AU3344093A (en) Brush
AU4978693A (en) Cleaning head
AU2441692A (en) Power-driven rotary toothbrush
AU5426994A (en) Toothbrush
AU3720793A (en) Toothpaste composition
AU3048492A (en) New compounds
AU3200493A (en) Ganglioside-GM3-fortified nutrient composition
AU4680393A (en) Disposable toothbrush
HK1008336A1 (en) Preparation of beta-methyl carbapenem intermediates
AU5082993A (en) Cationic-2-heteroarylphenyl-carbapenem antibacterial agents
AU5008993A (en) Cleaning composition
AU4746593A (en) BU-4803T antibiotics
AU645734B3 (en) A sponge for cleaning surfaces
AU3765393A (en) Bubblers
AU630326B3 (en) Double-threaded tooth pick
AU638924B3 (en) Inking head
AU3169093A (en) Cleaning

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20130201